Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Akcea Therapeutics, Inc.    AKCA

AKCEA THERAPEUTICS, INC.

(AKCA)
  Report
SummaryQuotesChartsNewsRatingsCompanyFinancials 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Sector news Pharmaceuticals - NEC
11/30BAYER : U.S. judge rejects $648 million Bayer PCB contamination settlement
RE
11/30Australia shares recover ground ahead of cenbank decision; China tensions wei..
RE
11/30Moderna files for U.S. vaccine authorization, will seek EU nod
RE
11/30COVID R&D Alliance launches trial of Amgen, UCB, Takeda drugs
RE
11/30ANALYSIS : Small caps set to keep surging as vaccines aid recovery
RE
11/30American Airlines conducts trials to transport COVID-19 vaccine
RE
11/30MERCK KGAA : Gets a Buy rating from Kepler Cheuvreux
MD
11/30Novavax expects delayed U.S. COVID-19 vaccine trial to start in coming weeks
RE
11/30Moderna to seek US, EU emergency authorization Monday after COVID-19 vaccine ..
RE
11/30ASTRAZENECA : UBS drops its Sell rating
MD
11/30Weight-Loss Firm Noom Names First CFO
DJ
11/30SINO BIOPHARMACEUTICAL : January-September Net Profit Fell 18%
DJ
11/30UK business confidence at four-month low but signs of vaccine boost - Lloyds
RE
11/30REGENERON PHARMACEUTICALS : Sanofi and Regeneron's Dupixent wins EU approval to ..
RE
11/29ASTRAZENECA : India regulators probe alleged AstraZeneca shot reaction, trial co..
RE
11/29UK secures two million more doses of Moderna's COVID-19 vaccine
RE
11/29ASTRAZENECA : UK confirms H5N8 bird flu on English turkey farm
RE
11/28Serum Institute CEO sees AstraZeneca's COVID-19 vaccine as "very good" candid..
RE
11/28Serum Institute CEO sees AstraZeneca's COVID-19 vaccine as "very good" candid..
RE
11/28UK regulator set to approve COVID-19 vaccine next week - FT
RE
11/28India's Modi visits key vaccine facilities as COVID-19 cases surge
RE
11/28India's Modi visits key vaccine facilities as COVID-19 case load surges
RE
11/27BIOGEN : bets on depression drug in $1.5 billion deal with Sage Therapeutics
RE
11/27SALESFORCE, DELTA AIR LINES, BEST BU : Stocks That Defined the Week
DJ
11/27United Begins Flying Pfizer's Covid-19 Vaccine -- Update
DJ
11/27Oil prices post weekly gain ahead of OPEC+ meeting
RE
11/27Nasdaq hits record high as holiday shopping begins
RE
11/27ASTRAZENECA : UK's MHRA Says It Got Health Dept Letter Requesting Review Of Oxfo..
RE
11/27ASTRAZENECA : Will COVID-19 vaccines protect us? Does efficacy equal effectivene..
RE
11/27ASTRAZENECA : WHO says it needs to evaluate vaccine candidates on more than just..
RE
11/27Ten COVID-19 vaccines seen by mid-year, head of global pharma group says
RE
11/27Vaccine Approval Race Gears Up as U.K. Asks for Emergency Review of AstraZene..
DJ
11/27Wall St rises, Nasdaq hits record high on recovery hopes
RE
11/27Swiss drugmaker Vifor had bid interest but talks halted - sources
RE
11/27Covid-19 Vaccine Studies May Suffer as Volunteers Consider Dropping Out
DJ
11/27Britain and other nations press on with AstraZeneca vaccine amid trial questi..
RE
11/27Britain and other nations press on with AstraZeneca vaccine amid trial questi..
RE
11/27SAGE THERAPEUTICS : Biogen bets on depression drug in $1.5 bln deal with Sage Th..
RE
11/27BIOGEN : Sage Therapeutics Reach Global Collaboration for Potential Depression a..
DJ
11/27NOVARTIS AG : Barclays reaffirms its Sell rating
MD
11/27EXCLUSIVE : Suspected North Korean hackers targeted COVID vaccine maker AstraZen..
RE
11/27Malaysia secures Pfizer vaccine in a first for Southeast Asia
RE
11/27PFIZER : Malaysia to Buy 12.8 Million Doses of Pfizer's Covid-19 Vaccine
DJ
11/27European shares rise for fourth straight week; Spain's BBVA jumps
RE
11/27British midcaps post weekly losses on Brexit woes, dour outlook
RE
11/27Malaysia secures Pfizer vaccine in a first for Southeast Asia
RE
11/27Philippines secures 2.6 mln doses of AstraZeneca's COVID-19 vaccine
RE
11/27ASTRAZENECA : says working with regulators on best approach to lower dose regime..
RE
11/27AstraZeneca CEO expects to run new global trial of COVID-19 vaccine - Bloombe..
RE
11/27Vaccine developer SK Bioscience targets IPO in first half of 2021
RE
1  2  3  4  5  6  7  8  9  10Next